Price
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for Molecular?
Molecular's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.148. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Molecular's stock?
Currently, 1 analysts cover Molecular's stock, with a consensus target price of 10.90. Analyst ratings provide insights into the stock's expected performance.
What is Molecular's revenue over the trailing twelve months?
Over the trailing twelve months, Molecular reported a revenue of 25.18M.
What is the EBITDA for Molecular?
Molecular's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 3.03M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Molecular?
Molecular has a free cash flow of -14.91M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Financials
- EPS (TTM)
- -$1.148
- Revenue (TTM)
- 25.18M
- EBITDA (TTM)
- 3.03M
- Free Cashflow (TTM)
- -14.91M
Analyst Ratings
The price target is 10.90 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Molecular Energies Plc engages in the exploration, development, and production of oil and gas properties. It focuses on the exploration of hydrocarbons. The company was founded on April 16, 2004 and is headquartered in Leeds, the United Kingdom.
- Industries
- Oil & Gas Production
- Sector
- Energy
Identifier
- ISIN
- GB00BMT80K89
- Primary Ticker
- MEN